Banca Mediolanum (BMED) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
FY 2023 net income reached €821.9m, up 62% YoY, while operating margin rose 49% to €987.7m.
Total assets under administration and management rose 14% to €118.07bn, supported by positive market effects and net inflows of €7.13bn.
Financial highlights
Net commission income was €1,029.5m, up 6% YoY; net interest income was €752.4m, up 85%, following 2023 rate increases.
Contribution margin increased 30% to €1,766.5m; positive market effects were €89.7m versus -€1.1m in FY 2022.
Profit before tax rose 66% to €1,067.2m; income tax was €245.3m and net income was €821.9m.
Outlook and guidance
Progressive upward repricing of assets is expected to continue into 2024; customer funding costs will be managed flexibly as a hedge against rate declines.
€1.84bn in money-market assets remains scheduled for transfer over the next 3–5 years through the Intelligent Investment Strategy.
Latest events from Banca Mediolanum
- Record earnings and €9.52bn inflows support growth and higher 2026 dividends.BMED
Q3 2026 - Net income up 16% to €555.5M, record assets, and robust growth across all core metrics.BMED
Q2 2026 - Q1 2026 net income up 13% to €276.2M, with strong asset growth and resilient inflows.BMED
Q1 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 2025 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 2025 - Net income up 24% to €449.9M, CET1 at 23.7%, and managed asset inflows guidance raised.BMED
Q2 2024 - Net income up 18% to €674.3M, assets at €133B, CET1 at 23.4%, interim dividend approved.BMED
Q3 2024 - Net income up 10–10.4% YoY to €243.3m, with record inflows and strong capital ratios.BMED
Q1 2025 - Record net income and €10.44B inflows drive 42% dividend hike; 2025 inflows to stay strong.BMED
Q4 2024